Kriya Therapeutics is a biopharmaceutical company focused on developing gene therapies for common diseases in ophthalmology, neurology, and metabolic disorders. With operations in Palo Alto and Research Triangle Park, the company has raised over $450 million to advance its pipeline of therapies.